Skip to main content
. 2020 Apr 28;10:165. doi: 10.3389/fcimb.2020.00165

Figure 1.

Figure 1

Low BMI is associated with diminished circulating levels of HNP1-3, granulysin, HBD-2 and cathelicidin. (A) The plasma levels of HNP1-3, granulysin, HBD-2, and cathelicidin (LL37) were measured by ELISA in LTBI-LBMI (n = 44), LTBI-NBMI (n = 44), and HC (n = 44) individuals. The data are depicted as scatter plots and each circle represents a single person. (open circle–LTBI with LBMI and light gray–LTBI with NBMI and dark gray- LTBI with HBMI). P-values were calculated using the Kruskal Wallis test with Dunn's multiple comparison test. (B) Relationship between the levels of HNP1-3, granulysin, HBD-2, and cathelicidin (LL37) and BMI in LTBI individuals. The relationship between the systemic levels of HNP1-3 and granulysin, HBD-2 and cathelicidin (LL37) and BMI were examined in all LTBI (n = 88) individuals. p and r-values were determined by Spearman rank correlation at 95% confidence intervals.